Structure–nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds
- 2 February 2007
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 114 (1) , 1-12
- https://doi.org/10.1016/j.pharmthera.2007.01.006
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Oxidative stress and neurodegeneration: where are we now?Journal of Neurochemistry, 2006
- Apoptosis effector mechanisms: A requiem performed in different keysApoptosis, 2006
- Involvement of Insulin/Phosphoinositide 3-Kinase/Akt Signal Pathway in 17β-Estradiol-mediated NeuroprotectionPublished by Elsevier ,2004
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004
- Neuroprotective Effects of a Novel Non–Receptor-Binding Estrogen AnalogueStroke, 2002
- Untangling the human estrogen receptor gene structureJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
- Coregulators of Estrogen Receptor ActionCritical Reviews™ in Eukaryotic Gene Expression, 2002
- Influence of estrogen replacement therapy on plasma lipid peroxidationMenopause, 2001
- 17-β Estradiol Protects Neurons from Oxidative Stress-Induced Cell Death in VitroBiochemical and Biophysical Research Communications, 1995
- The catechol estrogensJournal of Steroid Biochemistry, 1981